Davis Polk and Homburger advised ADC Therapeutics, while Cooley and Lenz & Staehelin advised the underwriter.ADC Therapeutics SA announced a registered secondary offering of 12,000,000 of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
